Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-08-16
2008-10-28
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
07442709
ABSTRACT:
Compounds represented by Formula (I):or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.
REFERENCES:
patent: 3951920 (1976-04-01), Senoo et al.
patent: 4975435 (1990-12-01), Campbell et al.
patent: 5118688 (1992-06-01), Campbell
patent: 5688809 (1997-11-01), Macur
patent: 5814651 (1998-09-01), Duplantier et al.
patent: 5972980 (1999-10-01), Cornicelli et al.
patent: 5990146 (1999-11-01), Boschelli et al.
patent: 6001866 (1999-12-01), Cornicelli et al.
patent: 6087380 (2000-07-01), Hauel et al.
patent: 6218388 (2001-04-01), Boschelli et al.
patent: 6316474 (2001-11-01), McCauley et al.
patent: 6329383 (2001-12-01), Hedgecock et al.
patent: 6348032 (2002-02-01), Sperl et al.
patent: 6348474 (2002-02-01), Kayakiri et al.
patent: 6414008 (2002-07-01), Hauel et al.
patent: 6444617 (2002-09-01), Takaishi et al.
patent: 6465484 (2002-10-01), Bilodwau et al.
patent: 6469039 (2002-10-01), Hauel et al.
patent: 6479508 (2002-11-01), Beaulieu et al.
patent: 6512000 (2003-01-01), Anderskewitz et al.
patent: 6548524 (2003-04-01), Levin et al.
patent: 2244908 (1973-03-01), None
patent: 0563001 (1993-09-01), None
patent: 0 706 795 (1996-04-01), None
patent: 0 846 689 (1998-06-01), None
patent: 1 085 372 (2001-03-01), None
patent: WO 97/12613 (1997-04-01), None
patent: WO 00/12089 (2000-03-01), None
patent: WO 00/15222 (2000-03-01), None
patent: WO 00/59888 (2000-10-01), None
patent: WO 00/76501 (2000-12-01), None
patent: WO 01/12600 (2001-02-01), None
patent: WO 01/14342 (2001-03-01), None
patent: WO 01/21634 (2001-03-01), None
patent: WO 01/57019 (2001-08-01), None
patent: WO 01/57020 (2001-08-01), None
patent: WO 02/04425 (2002-01-01), None
patent: WO 02/30886 (2002-04-01), None
patent: WO 02/059118 (2002-08-01), None
patent: WO 02/069965 (2002-09-01), None
patent: WO 02/076960 (2002-10-01), None
patent: WO 02/083143 (2002-10-01), None
patent: WO03087099 (2003-10-01), None
Patani & Lavoie, Bioisosterism: A Rational Approach, Chem. Rev. 96:3147-3176 (1996).
Grever et al., Seminars in Oncology, 19(6): 622-638 (1992).
Castelhano Arlindo L.
Crew Andrew Phillip
Dong Han-Qing
Laufer Radoslaw
Li An-Hu
Chung Susannah
OSI Pharmaceuticals, Inc.
Shiao Rei-tsang
LandOfFree
N3-substituted imidazopyridine c-Kit inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N3-substituted imidazopyridine c-Kit inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N3-substituted imidazopyridine c-Kit inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4016405